Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHC.L Regulatory News (PHC)

  • There is currently no data for PHC

Partnership

15 Feb 2007 09:04

Plant Health Care PLC15 February 2007 15 February 2007 PLANT HEALTH CARE FORMS PARTNERSHIP WITH AMERICAN SOYBEAN ASSOCIATION Plant Health Care Inc, a wholly owned subsidiary of Plant Health Care plc("Plant Health Care") and The American Soybean Association ("ASA") announce the2007 "N-Hibit Partnership" field trail programme that will evaluate PlantHealth Care's N-Hibit Seed Treatment, as a tool to lower Soyabean Cyst Nematode(SCN) and improve soybean plant health, during the 2007 growing season. The ASA represents a significant majority of the US soybean growers who plantedsome 75 million acres of soybeans in the US last year. N-Hibit is a dry material that is not a restricted use product. It is easy toapply, has an excellent safety profile and leaves no residuals in the water,soil or on plants. University field research has shown that N-Hibit reduces SCN eggs significantly.Other replicated and commercial research trails have also shown that N-Hibitincreases root and plant growth and increases soybean yield by about 6.5 percent per acre. The active ingredient in N-Hibit and other Harp-N-Tek products is harpinprotein, which is produced by disease causing bacteria that attack plants.Harp-N-Tek products do not contain pathogens, but cause the plant to respond asthough being attacked. Harpin proteins do not enter the plant. They bind withthe plant's external harpin protein receptors, which are present on seed, aswell as foliage. This turns on the plant's natural self defence and growthsystems. Then the harpin proteins harmlessly disintegrate ASA Vice President, Rob Joslin said: "ASA views this field trial program as anopportunity for its members to maximize soybean yield and profitability, andreduce the threat of SCN damage. We believe soybean growers will want to conducttheir own on-farm trials to determine results with N-Hibit on a commercial scaleunder their own growing conditions and management systems to help document theperformance of this seed treatment." John Brady CEO of Plant Health Care said: "We are delighted to be working withthe ASA on the Field Trail Programme for N-Hibit, as it will show soybeangrowers across the US that this product is highly effective and can help themincrease yield per acre and hence their profits. This is the best introductionto the soybean industry and as a result of this association we fully expectsignificant penetration into this huge market by 2008/2009". For further information contact: Plant Health Care plcJohn Brady, CEO; phone: +1 603 525 3702E-Mail: jabrady@planthealthcare.com Tavistock ComunicationsJeremy Carey/Matt Ridsdale, phone: +44 20 7920 3150E-Mail: jcarey@tavistock.co.uk, mridsdale@tavistock.co.uk Notes to Editors: About Plant Health Care:Plant Health Care plc ("PHC") is a leading provider of natural products forplants and soil. Established in 1995 in Pittsburgh (Pennsylvania) in the UnitedStates, PHC currently has approximately 70 employees and has operations in theUS, Mexico, UK, Spain, and the Netherlands. The Company listed on the AIM marketof the London Stock Exchange in July 2004. Ticker symbol is PHC. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
14th Sep 20157:00 amRNSHalf Yearly Report
19th Aug 20157:00 amRNSBlocklisting Interim Review
13th Jul 20157:00 amRNSPHC Granted Product Registration in Brazil
18th Jun 20157:00 amRNSDirector/PDMR Shareholding
17th Jun 20152:20 pmRNSResult of AGM
2nd Jun 20157:00 amRNSRe Agreement
6th May 20157:01 amRNSPlant Health Care Hires Jeff Tweedy
30th Apr 20153:02 pmRNSTotal Voting Rights
22nd Apr 20153:05 pmRNSTR1: Notificiation of Major Interest in Shares
17th Apr 20157:00 amRNSDIRECTORS' DEALING
15th Apr 20157:00 amRNSAnnual Report 2014 and Notice of AGM
8th Apr 20157:00 amRNSRe Agreement
30th Mar 20157:00 amRNSAnnual Financial Report
27th Mar 20157:00 amRNSDirectorate Change
5th Mar 201512:30 pmRNSPlant Health Care signs Distribution Agreement
20th Feb 20155:48 pmRNSBlocklisting Interim Review
17th Feb 20154:03 pmRNSHolding(s) in Company
30th Jan 20157:00 amRNSBoard changes and trading update
15th Dec 20141:51 pmRNSTR-1: Notification of Major Interest in Shares
5th Dec 20147:00 amRNSPHC Signs Agreement With Arysta LifeScience
19th Nov 20147:00 amRNSPlant Health Care Hires LHA
11th Nov 20144:05 pmRNSHolding(s) in Company
30th Oct 20147:00 amRNSPHC & Sipcam Enter Agreement
27th Oct 20147:00 amRNS3G Peptide Technology Platform shows major promise
23rd Oct 20144:29 pmRNSHolding(s) in Company
6th Oct 201411:25 amRNSDirector/PDMR Shareholding
2nd Oct 20147:00 amRNSDirector/PDMR Shareholding
15th Sep 20147:00 amRNSHalf Yearly Report
19th Aug 201410:28 amRNSAIM Blocklisting Return
12th Aug 20143:10 pmRNSTR-1 Notification of Major Interest in Shares
22nd Jul 20144:10 pmRNSTR-1 Notification of Major Interest in Shares
30th Jun 20149:18 amRNSTotal Voting Rights
5th Jun 201412:45 pmRNSTR-1 Notification of Major Interest in Shares
22nd May 20147:00 amRNSDelisting of shares from the CISX
8th May 20141:30 pmRNSAGM Voting Results
15th Apr 201411:30 amRNSDirector/PDMR Shareholding
15th Apr 20147:00 amRNSDirector/PDMR Shareholding
9th Apr 20142:15 pmRNSDirector's Dealing - Grant of Share Options
9th Apr 20142:00 pmRNSTR-1 Notification of Major Interest in Shares
7th Apr 20145:15 pmRNSPublication of Annual Report 2013 & Notice of AGM
31st Mar 20143:45 pmRNSTotal Voting Rights
24th Mar 20147:00 amRNSPreliminary Results
3rd Mar 20144:35 pmRNSPrice Monitoring Extension
28th Feb 20141:00 pmRNSTotal Voting Rights
19th Feb 201412:15 pmRNSBlocklisting Interim Review
17th Feb 20149:45 amRNSTR-1 Notification of Major Interest in Shares
6th Feb 20144:40 pmRNSSecond Price Monitoring Extn
6th Feb 20144:35 pmRNSPrice Monitoring Extension
31st Jan 20143:00 pmRNSTotal Voting Rights
15th Jan 20147:00 amRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.